Source:http://linkedlifedata.com/resource/pubmed/id/16176418
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-9-22
|
pubmed:abstractText |
The objective of the present study was to define the risk factors for hypertension and to analyze the influence of insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) on hypertension in pediatric renal transplant recipients. Twenty-six pediatric renal transplant recipients with stable renal function and treated with the same immunosuppression protocol were included in the study. Their mean age was 12.5 +/- 3.3 yr and mean time after transplantation was 38.5 +/- 39.8 month. Twenty-four hour ambulatory blood pressure monitoring (ABPM) was performed by SpaceLabs (90207) device. The I/D polymorphism of the ACE was determined by PCR and ACE serum level was analyzed by colorimetric method. Hypertension was present in 15 patients (57.7%) by causal blood pressure measurements and 19 patients (73.1%) by ABPM. Twenty-two patients (84.6%) were found to be non-dipper and eight of them had reverse dipping. Only time after transplantation (38 +/- 31 vs. 79 +/-49 month, p = 0.016) and cyclosporin A trough plasma levels (206 +/-78 vs. 119 +/- 83 ng/mL, p = 0.020) influenced the presence of hypertension by multiple logistic regression analysis. The distribution of genotypes were II = 2 (7.7%), ID = 8 (30.8%), DD = 16 (61.5%). There was no effect of ACE gene I/D polymorphism or serum ACE levels on hypertension prevalence and circadian variability of blood pressures. Hypertension was related to the time after transplantation and cyclosporin A levels. The ACE gene I/D polymorphism and serum ACE levels did not influence the blood pressure values or circadian variability of blood pressure among pediatric renal transplant patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1397-3142
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
612-7
|
pubmed:meshHeading |
pubmed-meshheading:16176418-Blood Pressure Monitoring, Ambulatory,
pubmed-meshheading:16176418-Child,
pubmed-meshheading:16176418-Female,
pubmed-meshheading:16176418-Humans,
pubmed-meshheading:16176418-Hypertension,
pubmed-meshheading:16176418-Immunosuppressive Agents,
pubmed-meshheading:16176418-Kidney Transplantation,
pubmed-meshheading:16176418-Male,
pubmed-meshheading:16176418-Peptidyl-Dipeptidase A,
pubmed-meshheading:16176418-Polymorphism, Genetic
|
pubmed:year |
2005
|
pubmed:articleTitle |
Hypertension and ace gene insertion/deletion polymorphism in pediatric renal transplant patients.
|
pubmed:affiliation |
Department of Pediatric Nephrology, Ege University Medical School, Izmir, Turkey. erkin@med.ege.edu.tr
|
pubmed:publicationType |
Journal Article
|